"Pfizer directors worry the company's shares, now trading at a 10½-year low of $19.18, would plunge to $10 or $12."

Story in the Wall Street Journal.

My prediction: Jeff Kindler will be gone within five years, unless he makes another major acquisition.

And another one.

And another one . . .